1. Vitamin B12 may play a preventive role in esophageal precancerous lesions: a case–control study based on markers in blood and 3-day duplicate diet samples
- Author
-
Ming Su, Ziyu Zhang, Ziqi Guo, Xiaopan Zhu, Guiju Sun, Shaokang Wang, Mengjing Cui, Niannian Wang, Mahsa Ghahvechi Chaeipeima, and Da Pan
- Subjects
0301 basic medicine ,Vitamin ,030109 nutrition & dietetics ,Nutrition and Dietetics ,business.industry ,Case-control study ,Medicine (miscellaneous) ,chemistry.chemical_element ,Physiology ,030209 endocrinology & metabolism ,Tumor initiation ,medicine.disease_cause ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,chemistry ,Tumor progression ,Medicine ,Vitamin B12 ,business ,Carcinogenesis ,Cobalt ,Duplicate diet - Abstract
It is hypothesized that vitamin B12 may prevent tumor initiation during the early stage of carcinogenesis such as esophageal precancerous lesions (EPL), whereas an excessive level may promote tumor progression during the later stages of carcinogenesis. This study aimed to determine the role of vitamin B12 in EPL by detecting vitamin B12-related markers in both blood and diet. This case–control study based on 3-day duplicated diet samples was conducted in a high-risk area of Huai'an, China. A 100 EPL cases and 100 healthy controls matched by gender, age (± 2 years) and villages were included. Dietary intake of vitamin B12 and cobalt, plasma cobalt level, the serum levels of vitamin B12 and transcobalamin II (TC II) were quantitatively analyzed. Dietary vitamin B12 intake (p for trend = 0.384) and plasma cobalt level (p for trend = 0.253) were not associated with EPL risk, but high dietary cobalt intake (p for trend = 0.034), increased serum levels of vitamin B12 (p for trend = 0.036) and TC II (p for trend
- Published
- 2021
- Full Text
- View/download PDF